Journals / Türk Göğüs Kalp Damar Cerrahisi Dergisi / 2011 / Cilt: 19 - Sayı: 1

The role of endoscopic lung volume reduction in the treatment of emphysema

Amfizem tedavisinde endoskopik akciğer hacim küçültme işleminin rolü

Pages
116–126
Publication Date
2022-09-02
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The aim of this article is to give an overview of the techniques and the available data.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Chronic obstructive pulmonary disease is a group of lung diseases characterized by chronic airflow obstruction and hyperinflation.
📊
Key Findings & Data:Evidence-based reviews of management approaches, providing stepped-care algorithms for pharmacological and non-pharmacological therapy have been published.
💡
Conclusion & Impact:The aim of this article is to give an overview of the techniques and the available data.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Chronic obstructive pulmonary disease is a group of lung diseases characterized by chronic airflow obstruction and hyperinflation. Evidence-based reviews of management approaches, providing stepped-care algorithms for pharmacological and non-pharmacological therapy have been published. In the last decades, many studies were conducted in order to design additional non-pharmacologic approaches, especially for patients with emphysema. Clinical studies performed with three different endoscopic lung volume reduction techniques have shown promising data and reached later stage clinical trials in patients with heterogeneous emphysematous diseases. These three techniques include reversible airway blocking techniques, reversible non-blocking techniques and irreversible non-blocking techniques. For homogeneous disease the formation of airway bypass tracts is being investigated. The aim of this article is to give an overview of the techniques and the available data.

Özet

Kronik obstrüktif akciğer hastalığı, kronik hava yolu obstrüksiyonu ve hiperinflasyon ile karakterize bir grup akciğer hastalığıdır. Farmakolojik ve farmakolojik olmayan tedavi algoritmaları sunan kanıta dayalı tedavi yaklaşımı incelemeleri yayımlanmıştır. Son birkaç on yılda, özellikle amfizemli hastalar için olmak üzere, farmakolojik olmayan ek tedavi yöntemlerinin geliştirilmesine yönelik birçok çalışma yapılmıştır. Üç farklı endoskopik hacim küçültme yöntemi umut vaat etmiştir ve heterojen amfizemli hastalar üzerinde yürütülen ileri faz klinik çalışmalara ulaşılmıştır. Bu üç yöntem, geri çevrilebilir hava yolu bloke etme tekniklerini, hava yolunu bloke etmeyen geri çevrilebilir teknikleri ve hava yolunu bloke etmeyen geri çevrilemeyen teknikleri içermektedir. Homojen hastalık için hava yolu bypass yolları oluşturulması araştırılmaktadır. Bu makale teknikler ve mevcut veriler konusunda bir genel bakış sağlamak amacıyla hazırlanmıştır.

🔖

Cite This Article

BOSTANCI, K., EBERHARDT, R., HERTH, F. J. F. (2022). The role of endoscopic lung volume reduction in the treatment of emphysema. Türk Göğüs Kalp Damar Cerrahisi Dergisi, Cilt: 19 - Sayı: 1, 116–126. https://ajindex.com/articles/424859

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med 1995;152:S77-121
  2. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007;370:765-73
  3. Ambrosino N, Simonds A. The clinical management in extremely severe COPD. Respir Med 2007;101:1613-24
  4. Fessler HE, Permutt S. Lung volume reduction surgery and airflow limitation. Am J Respir Crit Care Med 1998; 157:715-22
  5. Gelb AF, Brenner M, McKenna RJ Jr, Zamel N, Fischel R, Epstein JD. Lung function 12 months following emphysema resection. Chest 1996;110:1407-15
  6. Gelb AF, McKenna RJ, Brenner M, Fischel R, Zamel N. Lung function after bilateral lower lobe lung volume reduction surgery for alpha1-antitrypsin emphysema. Eur Respir J 1999; 14:928-33
  7. Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, et al. A randomized trial comparing lung-volumereduction surgery with medical therapy for severe emphysema. N Engl J Med 2003;348:2059-73
  8. Naunheim KS, Wood DE, Krasna MJ, DeCamp MM Jr, Ginsburg ME, McKenna RJ Jr, et al. Predictors of operative mortality and cardiopulmonary morbidity in the National Emphysema Treatment Trial. J Thorac Cardiovasc Surg 2006;131:43-53
  9. Naunheim KS, Wood DE, Mohsenifar Z, Sternberg AL, Criner GJ, DeCamp MM, et al. Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg 2006;82:431-43
  10. Wood DE. Results of lung volume reduction surgery for emphysema. Chest Surg Clin N Am 2003;13:709-26
  11. Criner GJ, Sternberg AL. National Emphysema Treatment Trial: the major outcomes of lung volume reduction surgery in severe emphysema. Proc Am Thorac Soc 2008;5:393-405
  12. Hamacher J, Russi EW, Weder W. Lung volume reduction surgery: a survey on the European experience. Chest 2000; 117:1560-7
  13. Chang AC, Chan KM, Martinez FJ. Lessons from the national emphysema treatment trial. Semin Thorac Cardiovasc Surg 2007;19:172-80
  14. Meyers BF, Patterson GA. Chronic obstructive pulmonary disease. 10: Bullectomy, lung volume reduction surgery, and transplantation for patients with chronic obstructive pulmonary disease. Thorax 2003;58:634-8
  15. Trulock EP, Christie JD, Edwards LB, Boucek MM, Aurora P, Taylor DO, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-four